The Merle Pattern: Beauty and Biology
Few coat patterns in dogs generate as much fascination and controversy as merle. The diluted patches of color set against darker base tones, the blue or parti-colored eyes, the irregular symmetry that makes each merle dog unique — these characteristics have made merle one of the most desired and commercially exploited color patterns in companion dog breeding. Yet merle is also associated with a cluster of serious health risks when handled carelessly, and understanding its molecular biology is essential for any breeder working with Australian Shepherds, Border Collies, Shelties, or any of the many other breeds where the merle pattern appears.
The story of merle is fundamentally a story about how a single genetic element, a transposable piece of DNA, disrupts a pigmentation pathway in ways that also affect neural crest cell development, with consequences that extend far beyond coat color.
The Molecular Basis of Merle
The merle phenotype is caused by a retrotransposon insertion in the PMEL17 gene (also called SILV), located on chromosome 10. Specifically, a short interspersed nucleotide element (SINE) has been inserted into an intron of PMEL17. This SINE insertion disrupts the normal processing of the PMEL17 mRNA transcript in some cells but not others, creating the characteristic patchy dilution seen in merle coats.
PMEL17 encodes a protein involved in melanin synthesis within melanosomes, the specialized organelles where pigment is produced. When the SINE disrupts PMEL17 function in a given melanocyte, that cell fails to produce normal amounts of eumelanin, producing a lighter or unpigmented patch instead. The apparently random nature of which cells are affected — and hence the irregular, marbled appearance of the merle pattern — reflects variation in how efficiently the cellular machinery splices around the inserted element in different developmental contexts.
Understanding this mechanism helps explain why merle interacts with other color genes in predictable ways. A dog that is e/e at the E locus, expressing only phaeomelanin (red/yellow pigment), will show no visible merle effect because the PMEL17 pathway affects eumelanin, not phaeomelanin. Such a dog may be a “hidden merle” or “phantom merle,” genetically merle but appearing solid red or cream. This has important implications for breeding, which we will return to shortly.
Cryptic Merle and the Instability of the SINE Insertion
One of the most genetically interesting aspects of the merle locus is the instability of the causative SINE insertion. The SINE responsible for merle varies in length, and this length variation correlates with phenotypic expression:
Full merle (M): Inserts of approximately 250 base pairs produce the classic merle phenotype in eumelanin-expressing dogs.
Cryptic/minimal merle (Mc or m^c): Shorter SINE variants (approximately 200 base pairs or less) produce dogs that appear phenotypically normal or show only subtle merle markings, yet carry a merle allele. These dogs are sometimes called “ghost merles” because they can produce merle offspring from apparently non-merle matings.
Atypical merle: Intermediate insert lengths can produce partial or atypical merle expression, including the “harlequin-like” patterns seen occasionally in Australian Shepherds.
This continuum of expression, governed by SINE length, makes simple genotyping for “merle/non-merle” insufficient for some breeding decisions. DNA testing that specifies the SINE length provides the most complete picture of what an individual dog might produce in a litter.
For herding breed breeders who care about understanding all dimensions of their dogs’ genomic profiles, the merle locus sits alongside other coat color considerations discussed in our coat color genetics guide.
The Health Consequences of Merle
The PMEL17 disruption does not only affect melanocytes in the skin and hair follicles. Neural crest cells, the embryonic cells that develop into melanocytes, also contribute to the development of the inner ear and parts of the eye. When merle disrupts PMEL17 function in these neural crest-derived structures during embryonic development, the consequences can include:
Ocular anomalies: Merle-associated eye conditions include microphthalmia (abnormally small eyes), colobomas (developmental defects in eye structures), irregular pupil shape, and increased rates of hereditary eye conditions unrelated to the merle mechanism itself. Blue eyes are frequently seen in merle dogs and are caused by the absence of pigment in the iris, not by a separate gene variant.
Hearing deficits: The stria vascularis of the inner ear requires melanocytes for normal function. When melanocyte development is disrupted by merle, the stria vascularis fails to develop normally, potentially resulting in unilateral or bilateral deafness. The probability and severity of hearing deficits increases substantially with the degree of white pigmentation on the head.
Pigmentation-linked neurological development: The connection between pigmentation genes and neural development is a recurring theme in canine genetics. As described in our behavioral genetics article, there may be broader interactions between coat color loci and neural phenotypes beyond the documented sensory deficits.
In a single-copy merle dog (Mm), these health risks are present but relatively modest. Most single merle dogs have normal eyes and hearing, though careful ophthalmologic screening and BAER testing (brainstem auditory evoked response testing) are recommended for merle breeding stock.
Double Merle: The Serious Problem
The critical health risk associated with merle occurs when two merle dogs are bred together. Each parent passes a merle allele to 50% of their offspring, meaning that on average, 25% of the litter will inherit two copies of the merle allele — double merle, or homozygous merle.
Double merle dogs show dramatically elevated rates of severe microphthalmia, anophthalmia (absence of one or both eyes), bilateral deafness, and other developmental anomalies. The penetrance of severe defects in double merle dogs is high enough that intentional merle × merle breeding is widely condemned by veterinary organizations, major breed clubs, and animal welfare bodies.
Crucially, the same risk applies when a visible merle is bred to a cryptic merle that appears non-merle. A dog with a cryptic merle allele can produce double merle offspring despite appearing solid-colored, which is why DNA testing to identify cryptic merles is essential before breeding decisions are made.
Australian Shepherds: A Breed Defined by Merle
The Australian Shepherd is perhaps the breed most publicly associated with the merle pattern, partly because merle is common in the breed and partly because Aussies have become enormously popular as companion dogs with non-specialist owners. The breed’s striking tricolor merle appearance is central to its commercial appeal and has driven demand for merle puppies from breeders who may not understand the associated genetics.
In Aussies, responsible merle × non-merle breeding has been practiced by serious breeders for generations. The challenge has intensified as the breed’s popularity has attracted less informed producers who breed merle × merle intentionally to produce what they market as “double merle” or “rare white” puppies. These dogs are sold at premium prices to buyers who may not be aware of the health implications.
The Australian Shepherd Club of America, among other organizations, has long-standing policies against merle × merle breeding and recommends BAER testing and ophthalmologic examination for all merle breeding stock. Despite these guidelines, enforcement is impossible without breed club oversight of individual breeders, and the companion dog market remains a source of preventable double merle production.
Border Collies: Merle in a Working Context
Merle occurs in Border Collies but has historically been less central to the breed’s identity than in Aussies. The International Sheep Dog Society (ISDS), which maintains the primary working Border Collie registry, has traditionally been relatively indifferent to coat color because the working test determines registration eligibility. This means working Border Collie populations tend to have lower merle allele frequencies than show or companion lines.
However, the crossover between working lines and companion/show markets in recent decades has introduced merle more broadly into Border Collie breeding in some countries. As with Aussies, the same genetic principles apply: DNA testing to identify cryptic merles, avoiding merle × merle pairings, and BAER testing for merle breeding stock.
The genetic bottleneck considerations that shape Border Collie breeding more broadly, discussed in our article on genetic bottlenecks in herding breeds, interact with merle allele management. When effective population sizes are small, a popular merle sire can rapidly increase merle allele frequency in a regional population beyond levels that responsible breeding can easily manage.
What DNA Testing for Merle Tells You
Commercial canine DNA testing now routinely includes merle status, and higher-resolution testing that specifies SINE insert length is available from several specialized laboratories. When reviewing results:
M/m results: A single merle allele. The dog shows merle coloring (unless it is also e/e). Should never be bred to another M carrier.
M/M results: Double merle. Should not be bred and warrants immediate veterinary evaluation for ocular and auditory deficits.
Mc/m or similar: One cryptic merle allele. The dog appears non-merle but can produce merle offspring. Critically important information for breeding decisions.
m/m: Non-merle at both alleles. Safe to breed to any merle status without risk of double merle offspring.
All merle breeding stock should have both genotypic results (DNA test) and phenotypic health screening (BAER test and ophthalmologic examination) documented. The combination of tests provides the most complete risk assessment available.
The Ethics of Merle Breeding
The merle discussion inevitably leads to broader questions about aesthetic-driven breeding and the responsibility breeders bear to the dogs they produce. The market demand for merle dogs has created significant financial incentives that can override health considerations, particularly in commercial breeding operations outside the oversight of breed clubs.
The availability of accurate, affordable DNA testing removes the information gap that might once have justified ignorance. A breeder producing merle × merle litters in 2026 cannot claim unknowing: the genetic facts are well established, the tests are available, and the health outcomes for double merle dogs are well documented. The choice to breed merle × merle is an ethical one, not merely a technical one.
For anyone considering breeding dogs with merle genetics, the framework established in serious herding breed communities — test, screen, document, and never breed merle to merle — represents both best practice and basic responsibility to the animals in one’s care.